Inversiones La Construcción (ILC) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Oct, 2026Executive summary
9M25 profit was Ch$186,449 million, up 68.1% YoY; Q3 profit rose 25.2% to Ch$72,436 million, despite a Ch$18,328 million after-tax Isapres liability adjustment.
Growth reflected stronger financial markets and operating progress across subsidiaries; consolidated ROAE was 19.2%.
Financial highlights
9M25 net operating income was Ch$218,310 million versus Ch$114,024 million in 9M24; non-operating loss was Ch$2,136 million versus income of Ch$5,024 million.
At September 2025, assets were Ch$17,681,640 million, up 7.2% from year-end 2024; liabilities rose 7.2% and controlling equity rose 7.1%.
Shares returned 101.0% YTD through November 21, 2025, with 7.9% dividends, versus 46.6% for the IPSA.
Outlook and guidance
Banking priorities include expanding retail financing and corporate relationships, diversifying products and funding, and developing digitally onboarded products.
RedSalud is pursuing broader access and growth in high-complexity services; strategic priorities include growth, diversification, profitability, flexibility and sustainability.
Latest events from Inversiones La Construcción
- Diversification sets the stage for growth and ambitious bank and annuity profit targets.ILC
Investor Day 2023 - Diversified financial and healthcare growth sets the course for 2030.ILC
Corporate presentation - Q1 profit rose 44.3%, driven by financial subsidiaries despite healthcare margin pressure.ILC
Q1 2023 - FY23 profit rose 24.6%, led by stronger non-operating income and Consalud’s turnaround.ILC
Q4 2023 - Q1 profit rose 69.9%, as financial-subsidiary gains offset Consalud’s GES-related loss.ILC
Q1 2024 - Q2 adjusted profit was offset by weaker markets and Consalud’s Short Law liability.ILC
Q2 2024 - Q3 profit rose 61.6%; 9M24 profit grew 14.4% excluding Consalud’s liability.ILC
Q3 2024 - FY24 profit was Ch$180.614bn before the Short Law liability, down 1.1% YoY.ILC
Q4 2024 - Market volatility cut earnings, partly offset by stronger healthcare and banking results.ILC
Q1 2025